Search
Now showing items 1-7 of 7
Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study
(CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, 2013)
…
Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study
(TURKISH SOC CARDIOLOGY, 2016)
Objective: The present objective was to determine frequency of Arginine389Glycine (Arg389Gly) and Cytochrome p450 2D6*10 (Cyp2D6*10) polymorphism in cases of heart failure-reduced ejection fraction (HFREF), and to evaluate ...
Ischemia-modified albumin in patients presenting with acute decompensated heart failure: IMA-HF study
(WILEY-BLACKWELL, 2012)
…
Relationship between functional capacity and socioeconomic status in a cohort of Turkish heart failure patients
(TURKISH SOC CARDIOLOGY, 2016)
Objective: New York Heart Association (NYHA) classification predicts prognosis for heart failure (HF) patients. Socioeconomic status (SES) has the potential to affect treatment strategy and disease course. The present ...
2016 ESC and ACC/AHA/HFSA heart failure guideline updates: Changes, similarities, differences, and unresolved isssues
(TURKISH SOC CARDIOLOGY, 2016)
…
Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction
(TURKISH SOC CARDIOLOGY, 2015)
Objective: In heart failure (HF) patients, functional capacity has been demonstrated to be a marker of poor prognosis, independent of left ventricular ejection fraction (EF). Lymphocyte count is currently recognized in ...